Bioatla, Inc. (BCAB)
NASDAQ:BCAB
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.00M | $ 11.00M | $ 0.00 | $ 0.00 | $ 250.00K |
| Gross Profit | $ 2.00M | $ 10.07M | $ -1.22M | $ -1.20M | $ 250.00K |
| Operating Income | $ -59.30M | $ -73.94M | $ -129.69M | $ -108.14M | $ -96.44M |
| EBITDA | $ -58.93M | $ -73.02M | $ -122.24M | $ -105.28M | $ -94.07M |
| Net Income | $ -59.61M | $ -69.78M | $ -123.46M | $ -105.28M | $ -95.40M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 7.12M | $ 49.05M | $ 111.47M | $ 215.51M | $ 244.98M |
| Total Assets | $ 13.83M | $ 52.42M | $ 119.66M | $ 225.74M | $ 254.42M |
| Total Debt | $ 6.20M | $ 836.00K | $ 2.46M | $ 3.98M | $ 5.37M |
| Net Debt | $ -918.00K | $ -48.21M | $ -109.01M | $ -211.53M | $ -239.61M |
| Total Liabilities | $ 50.02M | $ 38.16M | $ 48.99M | $ 45.40M | $ 43.60M |
| Stockholders' Equity | $ -36.19M | $ 14.27M | $ 70.67M | $ 180.34M | $ 210.82M |
| Cash Flow | |||||
| Free Cash Flow | $ -48.20M | $ -71.94M | $ -104.11M | $ -90.69M | $ -63.14M |
| Operating Cash Flow | $ -48.20M | $ -71.94M | $ -104.02M | $ -90.42M | $ -62.21M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ -98.00K | $ -265.00K | $ -924.00K |
| Financing Cash Flow | $ 6.28M | $ 9.51M | $ 77.00K | $ 61.21M | $ 69.51M |